MCF7 human breast adenocarcinoma cells were obtained from the Japanese Collection of Research Bioresources (JCRB; Osaka, Japan). A549 human lung carcinoma cells were kindly provided by Dr. Izumi Nagatomo and Dr. Haruhiro Hirata (Osaka University, Japan). HEK293T and HeyA8 cells were cultured in DMEM (Invitrogen), and SKOV3 and HT-29 cells were cultured in McCoy's 5a medium (Invitrogen). All media were supplemented with 10% fetal bovine serum, penicillin (100 IU/ml), and streptomycin (100μg/ml). MCF7 cells were cultured in Eagle's minimum essential medium with non-essential amino acids, 1 mM sodium pyruvate and 0.01 mg/ml insulin with 10% fetal bovine serum. A549 cells were cultured in DMEM (Invitrogen) with 10% fetal bovine serum, penicillin (100 IU/ml), and streptomycin (100μg/ml). Cells were maintained in a humidified incubator at 37℃ in a 5% CO 2 in air environment.
3.0% H2O2 for 30 min. After blocking nonspecific reactivity with goat serum for 10 min at room temperature, the sections were incubated overnight at 4°C with a primary antibody against UK) . The primary antibody was visualized using subsequent application of a secondary biotinylated antibody (Histofine SAB PO kit) and streptavidin-peroxidase (Histofine SAB PO kit). Immunostaining was developed using Envision DAB (Dako Ltd.) and the sections were counterstained with Mayer's haematoxylin. As a negative control, some sections were subjected to normal serum blocking with omission of the primary antibody. CD31: Tissues were frozen without fixation and sectioned at 100 μm thickness with a cryostat. Endogenous peroxidase was blocked by incubating the sections in 3.0% H2O2 for 30 min. After blocking nonspecific reactivity with rabbit serum for 10 min at room temperature, the sections were incubated overnight at room temperature in a rat anti-mouse CD31 monoclonal antibody (BD PharMingen, USA) diluted 1:200, followed by 30 min in biotin-labelled rabbit secondary anti-rat IgG antibody (Dako, USA) diluted 1:600. Immunostaining was developed using Envision DAB (Dako, USA), and the sections were counterstained with Mayer's haematoxylin.
As a negative control, some sections were subjected to normal serum blocking with omission of the primary antibody.
SI Figure Legend
Supplementary Figure S1 | Only excessive VEGF did not accelerate cell growth. To evaluate the effect of additional VEGF on cell proliferation, pLV-EGFP was transduced into HEK293T, SKOV3, HeyA8, and HT-29 cells, and at the same time as the transfection we added rVEGF into the culture media. The number of cells with or without additional rVEGF was not significantly different in HEK293T, SKOV3, HT-29, and HeyA8 cells. Supplementary Table S1 | The relationship between the concentration of sFLT1 in culture supernatants and the amounts of plasmid DNA. ELISAs. The relationship between the concentration of sFLT1 in culture supernatants and the amounts of plasmid DNA. Cells were seeded in 6-well plates at densities of 2×10 4 (HEK293T, HT-29 and HeyA8) and 4×10 4 (SKOV3) cells in 2mL of culture medium per well, respectively, and allowed to attach for 24 hours. Then, the cells were transfected with various concentrations of pLV-sFLT1. In HEK293T and HeyA8 cells, culture supernatants were collected 72 hours after transfection, and in SKOV3 and HT-29 cells, collected 96 hours after transfection. We determined the concentrations using commercial ELISA kits (R&D Systems) according to the manufacturer's specifications.
Supplementary Table S2 | The concentrations of sFLT1, VEGF and PlGF in supernatants of culture
dishes. ELISAs. The concentrations of sFLT1, VEGF and PlGF of supernatants of culture dishes revealed a correlation between lower concentration of VEGF and fewer cell numbers. We determined the concentrations using commercial ELISA kits (R&D Systems) according to the manufacturer's specifications.
.
Supplementary Table S3 | Evaluation of side effects caused by sFLT1 in ovarian cancer model mice. (a)
Systolic and diastolic blood pressure were measured at five weeks after initial treatment (n = 4). In intraperitoneal treatment experiments, the mean blood pressure of neither the rVEGFR1-2000ng nor the rVEGR1-200ng groups was elevated compared to the control group. On the other hand, with injection of transfected cells, the mean blood pressure of the sFLT1 group tended to be higher than that of the EGFP group. (P=0.16) (b) Urine albumin and creatinine concentrations were analyzed at five weeks after initial treatment. Student's t test was performed against the PBS group or the SKOV3-pLV-EGFP group as control.
The ratios of urinary albumin/urinary creatinine in the rVEFGR1 group or SKOV3-pLV-sFLT1 group was similar to those in the control group.
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